Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06382519
Thalidomide Therapy for VEOIBD
Sponsor: Children's Hospital of Fudan University
View on ClinicalTrials.gov
Summary
This is a single center, observational study to investigate the clinical outcomes of thalidomide treatment for very early onset inflammatory bowel disease
Official title: Thalidomide Therapy for Very Early Onset Inflammatory Bowel Disease
Key Details
Gender
All
Age Range
28 Days - 6 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2024-05-15
Completion Date
2026-12-31
Last Updated
2025-05-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
Thalidomide
thalidomide, dose 1.5-2.5mg/kg.d, orally taken before bedtime.
Locations (1)
Lin Wang
Shanghai, Shanghai Municipality, China